drugset / Trial / NCT05005455
Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to evaluate the pharmacokinetic similarity of bevacizumab with different manufacturing process in healthy male subjects. Another purpose is to determine safety, and immunogenicity of bevacizumab with different manufacturing process.
Timeline
- Start
- 2021-07-30
- Primary completion
- 2022-01-28
- Completion
- 2022-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 3 mg/kg | Intravenous |
Indications
No indication recorded.